TSE:COM 138267 (COM.TO) (COM) Stock Price, News & Analysis → WARNING about the death of the U.S. dollar… (From Colonial Metals) (Ad) Free COM Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$2.95▼C$2.9552-Week Range N/AVolume9,197 shsAverage Volume19,585 shsMarket CapitalizationC$102.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get 138267 (COM.TO) alerts: Email Address Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth About 138267 (COM.TO)Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of patients suffering from heart diseases. It offers BRINAVESS (vernakalant (IV)) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; XYDALBA, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections; and TREVYENT for the treatment of pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.Read More Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth COM Stock News HeadlinesApril 30, 2024 | forbes.comConvert Turkish Lira To LiteCoinFebruary 3, 2024 | finance.yahoo.comHilton Metal Forging Limited (HILTON.NS)October 2, 2023 | msn.comAryna Sabalenka: "Paula Badosa is my soulmate"September 1, 2023 | finance.yahoo.comBrunswick Exploration Inc. (BRWXF)August 12, 2023 | forbes.comConvert Malaysian Ringgit To New Zealand DollarJune 12, 2023 | forbes.comConvert Trinidad & Tobago Dollar To Guyanaese DollarMarch 21, 2023 | juniorminingnetwork.comLithium Energi Completes Debt Settlements, Creates New Credit Facility, and Closes Private PlacementAugust 18, 2022 | forbes.comNorth Carolina Income Tax Calculator 2021August 16, 2022 | forbes.comOhio Income Tax Calculator 2021July 5, 2022 | forbes.comTennessee Income Tax Calculator 2021July 5, 2022 | forbes.comCalifornia Income Tax Calculator 2021February 15, 2022 | forbes.comMissouri Income Tax Calculator 2021February 15, 2022 | forbes.comKansas Income Tax Calculator 2021January 21, 2022 | msn.com8,640 new Covid cases, 13 deaths FridayJanuary 5, 2022 | au.finance.yahoo.comOphir Asset Management Pty Ltd - Ophir High Conviction Fund (OPH.AX)See More Headlines Receive COM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 138267 (COM.TO) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:COM CUSIPN/A CIKN/A Webwww.cardiome.com Phone+1-604-6776905FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares34,639,000Free FloatN/AMarket CapC$102.19 million OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. William L. Hunter (Age 55)Pres, CEO & Director Ms. Sheila M. Grant MBAChief Operating OfficerMr. David D. McMasters (Age 59)Gen. Counsel Mr. Hugues SachotChief Commercial OfficerMr. Justin A. Renz (Age 46)Chief Financial Officer Key CompetitorsScythian BiosciencesCVE:SCYBNovoheartCVE:NVHSernovaTSE:SVAOncolytics BiotechTSE:ONCIntelGenx TechnologiesCVE:IGXView All Competitors COM Stock Analysis - Frequently Asked Questions Is 138267 (COM.TO) a good dividend stock? 138267 (COM.TO) (TSE:COM) pays an annual dividend of C$0.02 per share and currently has a dividend yield of 0.00%. What other stocks do shareholders of 138267 (COM.TO) own? Based on aggregate information from My MarketBeat watchlists, some companies that other 138267 (COM.TO) investors own include Aurora Cannabis (ACB), Aphria (APHA), Bombardier, Inc. Class B (BBD.B), Cardiome Pharma (CRME), Macy's (M), Meta Growth (NACNF), ProMetic Life Sciences (PLI), Teva Pharmaceutical Industries (TEVA), Hydropothecary (THCX) and AGT Food and Ingredients (AGT). How do I buy shares of 138267 (COM.TO)? Shares of COM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:COM) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersDividend-like income from non-dividend stocksUnstoppable ProsperityTop 5 Tech Stocks to Buy for 2024Daily Market AlertsThe most important AI company you've never heard ofManward PressBill Gates is all about this tiny $2 stockTimothy SykesTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon to Transform U.S. Economy? Porter & CompanyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 138267 (COM.TO) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.